Accrued Expenses and Other Current Liabilities

12 Months Ended

Dec. 31, 2023

Payables and Accruals [Abstract]

Accrued Expenses and Other Current Liabilities

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following:

	December 31,
	2023		2022
Accrued payroll	18,525		21,232
Deferred R&D credits	5,053		975
Rebates and customer advances	1,242		1,050
Interest payable	4,006		2,096
Accrued duty, freight and related expenses	4,005		5,314
Royalties	2,471		2,149
Value added tax payables	1,751		949
Other accrued expenses and liabilities	8,336		13,320
	$	45,389	$	47,085

Deferred R&D credits represent future offsets to research and development expense in the consolidated statement of operations. These credits were generated through the Company's participation in the U.K. Research and Development Expenditure Credit (RDEC) program.